Search filters

Filters
Clear All

Phase

  • 5
  • 3
  • 4
  • 5
  • 2
  • 50
  • 73
  • 37
  • 1
  • 7
  • 65

Found 73 Acute Lymphocytic Leukemia trials

A listing of Acute Lymphocytic Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Supporting Evidence-based Responses to Emotional Needs in Emphysema
18-100 years
All genders
Families play an important role in the experiences of patients with chronic illnesses, including chronic obstructive pulmonary disease (COPD). This study aims to identify how an evidence-based coping skills training program, where patients and a support person work together to manage and overcome disease-related distress, can reduce depression and anxiety …
 Genetic Testing in Young Adults With Cancer Study
18-40 years
All genders
Interventional
The overarching goal of our research is to define an evidence-based, sustainable approach to identifying and managing genetic risk among young adults with cancer and their relatives. Conventional practice leaves referral and testing decisions to mostly non-expert clinicians implementing complex guidelines at the point of care, leading to substantial under-utilization. …
 Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
18-39 years
All genders
Phase 3
Interventional
The first purpose of this study is to test the safety of the addition of a drug called inotuzumab to the usual chemotherapy drugs used for adolescent young adults (ages 18-39). Inotuzumab is investigational and is not FDA-approved. Additionally,this study is to compare any good and bad effects of using …
 HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
1 years and older
All genders
Phase 2
Interventional
This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated donors (MMUD) for peripheral blood stem cell transplant in adults and bone marrow stem cell transplant in children. Post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate mofetil (MMF) will be used for for …
 Naltrexone in AUD Reward Drinkers
18-65 years
All genders
Phase 4
Interventional
This study is a phase IV, two-arm, randomized, double-blind, placebo-controlled study to assess whether individuals identified as primarily reward drinkers are significantly more likely to reduce heavy drinking if they receive XR-NTX than a matching placebo injection. Study subjects will receive monthly injections of long-acting injectable naltrexone 380 mg (4 …
 Antiviral medication to reduce symptoms of COVID-19: A phase 3, placebo-controlled trial
18-64 years
All genders
Phase 3
If you tested positive for COVID-19 within the last 5 days, you may be eligible to participate in a research study to test the ability of a pill to reduce COVID-19 symptoms.
45-52 years
Accepts healthy volunteer
Female
The purpose of this study is to examine how depression symptoms develop when women begin the transition to menopause. This study will investigate depression symptoms by looking at how fluctuations in reproductive hormones (specifically, the hormone estradiol) might impact the body's biological sleep rhythms. This study will also look at …
18-60 years
All genders
Have problem with opiates? You may qualify for the study if you are:    - Between 18–60 years old    - In treatment or seeking treatment for opioid use problems    - Willing to complete one MRI scan of the brain  The study will investigate the psychological and brain mechanisms of opioid use disorder. There will be …
 The REMBRANDT Study (Recovery of the Microbiome from Antibiotics for Dental Implants)
60-100 years
All genders
The purpose of the study is to determine whether owning a pet changes the disruption and recovery of a person's microbiome (collection of bacteria in the intestines) following a course of antibiotics after they have received dental implant treatment.  
18 years and older
All genders
Phase 1
The study will evaluate the safety profile of escalating doses of continuous daily oral ATRN-119 and to determine the maximum tolerated dose (MTD) and recommended dose. ATRN-119 is a drug that has been developed to treat cancers by taking advantage of genetic mutations found only in the tumor and not …
1 - 10 of 73